[
  {
    "ts": "2025-08-15T14:00:11+00:00",
    "headline": "Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet",
    "summary": "David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",
    "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-pretty-healthy-140011516.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7b0a028c-3d99-31e3-8310-ec296a59f7eb",
      "content": {
        "id": "7b0a028c-3d99-31e3-8310-ec296a59f7eb",
        "contentType": "STORY",
        "title": "Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet",
        "description": "",
        "summary": "David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",
        "pubDate": "2025-08-15T14:00:11Z",
        "displayTime": "2025-08-15T14:00:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kwOAekfL2kTwyhkwu8ZhtQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YQK.80LOinov47ZlUhvOmQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-pretty-healthy-140011516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-nasdaq-amgn-pretty-healthy-140011516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-15T13:50:00+00:00",
    "headline": "SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease",
    "summary": "Sanofi wins EMA's orphan drug status for rilzabrutinib to treat IgG4-RD, a chronic, immune-mediated rare disease.",
    "url": "https://finance.yahoo.com/news/snys-rilzabrutinib-gets-eu-orphan-135000369.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a0ff2803-44b5-369e-9f2f-2659d3dd5390",
      "content": {
        "id": "a0ff2803-44b5-369e-9f2f-2659d3dd5390",
        "contentType": "STORY",
        "title": "SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease",
        "description": "",
        "summary": "Sanofi wins EMA's orphan drug status for rilzabrutinib to treat IgG4-RD, a chronic, immune-mediated rare disease.",
        "pubDate": "2025-08-15T13:50:00Z",
        "displayTime": "2025-08-15T13:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o4IYsXmA1G0eGuhNw0c16g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/43AXa9s.CTUHOV5OT2wzjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/snys-rilzabrutinib-gets-eu-orphan-135000369.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/snys-rilzabrutinib-gets-eu-orphan-135000369.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SNYNF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]